Literature DB >> 7501973

Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues.

G K Haines1, R Cajulis, R Hayden, R Duda, M Talamonti, J A Radosevich.   

Abstract

P68 is a potent inhibitor of protein synthesis in virally infected cells and has been suggested to function in noninfected cells as a tumor suppressor gene. We have previously demonstrated that p68 expression correlates directly with cellular differentiation and inversely with proliferative activity in normal epithelium and in several human tumor systems. In order to determine the role of p68 in human breast cancer, we utilized immunohistochemistry and mapped the expression of p68 in tissue from 200 breast biopsy specimens. A total of 434 foci, ranging from normal breast tissue to infiltrating carcinoma were examined. We found that p68 was present at basal levels in normal lobular and luminal ductal epithelial cells, with higher levels present in myoepithelial cells. Nonproliferative fibrocystic lesions showed variable expression of p68, with high levels seen within foci of apocrine metaplasia and low levels in cystically dilated terminal duct units. Low levels of p68 were seen in typical ductal proliferations, lobular neoplasia (atypical lobular hyperplasia and lobular carcinoma in situ), and in fibroadenomas. Foci of atypical ductal hyperplasia in situ and invasive ductal carcinoma generally showed higher levels of p68 expression. Among the infiltrating carcinomas, p68 expression correlated with nuclear grade. This suggests that the ability of p68 to inhibit cellular proliferation may be impaired in breast cancer and that its expression, although modestly paralleling cellular differentiation, is not a predictive indicator of improved survival.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 7501973     DOI: 10.1159/000217961

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

Review 2.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

3.  Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.

Authors:  Abujiang Pataer; Maria Gabriela Raso; Arlene M Correa; Carmen Behrens; Koji Tsuta; Luisa Solis; Bingliang Fang; Jack A Roth; Ignacio I Wistuba; Stephen G Swisher
Journal:  Clin Cancer Res       Date:  2010-10-07       Impact factor: 12.531

4.  Doxorubicin bypasses the cytoprotective effects of eIF2α phosphorylation and promotes PKR-mediated cell death.

Authors:  P Peidis; A I Papadakis; H Muaddi; S Richard; A E Koromilas
Journal:  Cell Death Differ       Date:  2010-06-18       Impact factor: 15.828

5.  Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.

Authors:  N Kunkeaw; S H Jeon; K Lee; B H Johnson; S Tanasanvimon; M Javle; C Pairojkul; Y Chamgramol; W Wongfieng; B Gong; C Leelayuwat; Y S Lee
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

Review 6.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 7.  Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells.

Authors:  Saravana Kumar Kailasam Mani; Ourania Andrisani
Journal:  Genes (Basel)       Date:  2018-03-02       Impact factor: 4.096

8.  High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.

Authors:  Ling Dai; Guangdong Pan; Xiaojia Liu; Jiang Huang; Zhiqing Jiang; Xiaobao Zhu; Xinli Gan; Qing Xu; Ning Tan
Journal:  Cancer Manag Res       Date:  2018-06-29       Impact factor: 3.989

9.  Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.

Authors:  Ling Yin; Yongji Zeng; Renya Zeng; Yuanhong Chen; Tian-Li Wang; Kerry J Rodabaugh; Fang Yu; Amarnath Natarajan; Adam R Karpf; Jixin Dong
Journal:  Oncogene       Date:  2021-11-19       Impact factor: 9.867

10.  Double-stranded RNA-dependent protein kinase regulates the motility of breast cancer cells.

Authors:  Mei Xu; Gang Chen; Siying Wang; Mingjun Liao; Jacqueline A Frank; Kimberly A Bower; Zhuo Zhang; Xianglin Shi; Jia Luo
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.